CVR: 67303016
Secondary names: AIR NORTH ApS, DANHEKO ApS, FITNESS PARTNER ApS
DKK 518,005,000
Revenue
Net result: DKK 26,711,000
PHARMCO I ApS, PharmCo III ApS
CVR · view ownership and management
Director role ended: Sven Moesgaard
CVR · 14/12/2020
View the full event history
PHARMA NORD ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 1981. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Eli Wallin. The company is owned by PHARMCO I ApS and PharmCo III ApS. The company has 199 employees (2018). In 2025, the company reported revenue of DKK 518,005,000 and a net result of DKK 26,711,000 compared with DKK 32,254,000 the year before. Equity in the 2025 report amounted to DKK 181,417,000.
Source: annual report 2025, Danish Business Authority
PHARMA NORD ApS demonstrates a stable financial health with a consistent revenue growth trajectory, increasing from 439.4 million DKK in 2022 to 518 million DKK in 2025. However, profit has shown volatility, peaking at 57.97 million DKK in 2021 before declining to 26.71 million DKK in 2025. The company's equity has fluctuated, ending at 181.4 million DKK in 2025, indicating a solid capital base but with some concerns regarding profit margins. Overall, PHARMA NORD maintains a significant position within the food manufacturing industry, although attention to profitability trends and equity management will be crucial for sustained growth.
AI-generated summary · Generated 10/06/2026
Selskabets formål er handel - herunder eksport, import - produktion samt anden i forbindelse hermed stående virksomhed, bl.a. restaurationsvirksomhed
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 518 mio. | 26.7 mio. | 473.5 mio. | 181.4 mio. | 473 | |
| 202401/01/2024 – 31/12/2024 | 486.7 mio. | 32.3 mio. | 405.3 mio. | 143.3 mio. | 440 | |
| 202301/01/2023 – 31/12/2023 | 447.4 mio. | 23.3 mio. | 427.1 mio. | 160.6 mio. | 416 | |
| 202201/01/2022 – 31/12/2022 | 439.4 mio. | 35.3 mio. | 447 mio. | 183 mio. | 425 | |
| 202101/01/2021 – 31/12/2021 | 470.2 mio. | 58 mio. | 460.6 mio. | 199.3 mio. | 420 | |
| 202001/01/2020 – 31/12/2020 | 417.2 mio. | 51.9 mio. | 415 mio. | 170.4 mio. | 394 | |
| 201901/01/2019 – 31/12/2019 | 333 mio. | 41.5 mio. | 392.6 mio. | 269.7 mio. | 375 | |
| 201801/01/2018 – 31/12/2018 | 334 mio. | 37.7 mio. | 356.8 mio. | 212.7 mio. | 364 | |
| 201701/01/2017 – 31/12/2017 | 343.1 mio. | 46.8 mio. | 336.2 mio. | 181.9 mio. | 378 | |
| 201601/01/2016 – 31/12/2016 | 337.3 mio. | 62 mio. | 319.1 mio. | 142 mio. | 315 | |
| 201501/01/2015 – 31/12/2015 | 417.5 mio. | 55.8 mio. | - | - | 307 | |
| 201401/01/2014 – 31/12/2014 | 317.1 mio. | 30.2 mio. | 327.5 mio. | 29.8 mio. | 285 | |
| 201301/01/2013 – 31/12/2013 | 317.4 mio. | 11.2 mio. | 342.1 mio. | -215 t. | 275 |
Compared to 169 companies in Fremstilling af andre fødevarer i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
4 properties
Upgrade to Pro to see addresses, building data and ownership details
Property report (PDF)
The entire property portfolio in one report: areas, usage, energy labels, flood exposure, planning zone and local plans.
See an example report (PDF)Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringPHARMA NORD ApS was founded on 2 October 1981.
PHARMA NORD ApS is registered under the industry Fremstilling af andre fødevarer i.a.n. (industry code 108900).
PHARMA NORD ApS had 199 employees in 2018 according to the Danish CVR register.
PHARMA NORD ApS is owned by PHARMCO I ApS and PharmCo III ApS.
In 2025, PHARMA NORD ApS reported revenue of DKK 518,005,000.
The management of PHARMA NORD ApS consists of Eli Wallin.
Claim this page to add your logo and social links. Free to get started.
PHARMA NORD ApS has published its annual report for 2025. Revenue came to DKK 518,005,000, and the net result was DKK 26,711,000.
PHARMA NORD ApS has published its annual report for 2024. Revenue came to DKK 486,691,000, and the net result was DKK 32,254,000.
As of May 30, 2025, Sven Moesgaard has left the board of directors of PHARMA NORD ApS.
PHARMA NORD ApS has published its annual report for 2023. Revenue came to DKK 447,388,000, and the net result was DKK 23,337,000.
PHARMA NORD ApS has published its annual report for 2022. Revenue came to DKK 439,437,000, and the net result was DKK 35,289,000.
PHARMA NORD ApS has published its annual report for 2021. Revenue came to DKK 470,180,000, and the net result was DKK 57,966,000.
PHARMA NORD ApS has published its annual report for 2020. Revenue came to DKK 417,178,000, and the net result was DKK 51,949,000.
As of December 14, 2020, Sven Moesgaard has stepped down as director of PHARMA NORD ApS.
PHARMA NORD ApS has published its annual report for 2019. Revenue came to DKK 332,992,000, and the net result was DKK 41,501,000.
As of May 29, 2020, Eli Wallin is registered as adm. dir. of PHARMA NORD ApS.
As of May 28, 2020, Eli Wallin has stepped down as director of PHARMA NORD ApS.
As of January 28, 2020, PharmCo III ApS is registered as an owner of PHARMA NORD ApS with an ownership share of 33%.
PHARMA NORD ApS has published its annual report for 2018. Revenue came to DKK 333,989,000, and the net result was DKK 37,712,000.
As of October 12, 2018, PHARMCO I ApS is registered as an owner of PHARMA NORD ApS with an ownership share of 50%.
PHARMA NORD ApS has published its annual report for 2017. Revenue came to DKK 343,074,000, and the net result was DKK 46,790,000.
PHARMA NORD ApS has published its annual report for 2016. Revenue came to DKK 337,277,000, and the net result was DKK 62,012,000.
PHARMA NORD ApS has published its annual report for 2015. Revenue came to DKK 417,476,102, and the net result was DKK 55,784,198.
PHARMA NORD ApS has published its annual report for 2014. Revenue came to DKK 317,138,255, and the net result was DKK 30,238,194.
PHARMA NORD ApS has published its annual report for 2013. Revenue came to DKK 317,354,452, and the net result was DKK 11,151,062.
As of February 12, 2014, Bent Henriksen has left the board of directors of PHARMA NORD ApS.
PHARMA NORD ApS has published its annual report for 2012.
As of October 4, 2010, Claus Hancke has left the board of directors of PHARMA NORD ApS.
As of November 4, 2009, Michael Christiani Havemann has joined the board of directors of PHARMA NORD ApS.
As of November 4, 2009, Claus Hancke has joined the board of directors of PHARMA NORD ApS.
As of November 4, 2009, Bent Henriksen has joined the board of directors of PHARMA NORD ApS.
As of November 4, 2009, Sven Moesgaard is registered as director of PHARMA NORD ApS.
As of October 21, 2009, MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of PHARMA NORD ApS.
As of October 21, 2009, H. MARTINSEN. STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of PHARMA NORD ApS.
As of February 25, 1997, H. MARTINSEN. STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of PHARMA NORD ApS.
As of August 15, 1991, has stepped down as auditor of PHARMA NORD ApS.
As of October 2, 1981, has been appointed auditor of PHARMA NORD ApS.
As of October 2, 1981, Sven Moesgaard has joined the board of directors of PHARMA NORD ApS.
As of October 2, 1981, Eli Wallin has joined the board of directors of PHARMA NORD ApS.
As of October 2, 1981, Eli Wallin is registered as director of PHARMA NORD ApS.
PHARMA NORD ApS was founded on October 2, 1981.
Companies in the same industry and area
